[{"Target": "GLP1R", "Drug": "Semaglutide", "Phase": "Approved", "MoA": "Agonist"}, {"Target": "GLP1R", "Drug": "Dulaglutide", "Phase": "Approved", "MoA": "Agonist"}, {"Target": "GLP1R", "Drug": "Orforglipron", "Phase": "Phase 3", "MoA": "Agonist"}, {"Target": "GIPR", "Drug": "Tirzepatide", "Phase": "Approved", "MoA": "Dual Agonist"}, {"Target": "GIPR", "Drug": "Retatrutide", "Phase": "Phase 3", "MoA": "Triple Agonist"}, {"Target": "SGLT2", "Drug": "Empagliflozin", "Phase": "Approved", "MoA": "Inhibitor"}, {"Target": "SGLT2", "Drug": "Dapagliflozin", "Phase": "Approved", "MoA": "Inhibitor"}, {"Target": "SLC30A8", "Drug": "Undisclosed ZnT8 Antagonist", "Phase": "Phase 1", "MoA": "Antagonist"}]